Sabra Health Care REIT Q4 Sales $163.40M Beat $158.10M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sabra Health Care REIT (SBRA) reported Q4 sales of $163.40M, surpassing the consensus estimate of $158.10M by 3.35%, but marking a 0.96% decrease from the previous year's $164.99M.
February 27, 2024 | 9:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT reported higher than expected Q4 sales of $163.40M, beating estimates by 3.35%, despite a slight year-over-year decrease.
Beating the consensus estimate for quarterly sales typically has a positive impact on investor sentiment and can lead to a short-term increase in stock price. However, the slight year-over-year decrease might temper some of the positive momentum.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100